The LifeSci Biotechnology Indexes are equal-weighted indexes that track the performance of U.S. - listed biotechnology stocks in two distinct stages in the lifecycle of biotechnology companies - Product stage and Clinical Trials stage. The indexes are calculated with a base value of 1,000 as of June 30, 2004 and have an official inception date of November 3, 2014.